Suriclone

TargetMol
Product Code: TAR-T28887
Supplier: TargetMol
CodeSizePrice
TAR-T28887-1mg1mg£188.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28887-5mg5mg£352.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28887-10mg10mg£496.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28887-25mg25mg£760.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28887-50mg50mg£1,018.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T28887-100mg100mg£1,348.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Suriclone is an anxiolytic drug belonging to the family of cyclopyrrolones. Suriclone has a very similar pharmacological profile to the benzodiazepine family of drugs including sedative and anxiolytic properties but with less amnestic effects. The mechanism of action by which suriclone produces its sedative and anxiolytic effects is by modulating GABA-A receptors, although suriclone is more subtype-selective than most benzodiazepines.
CAS:
53813-83-5
Formula:
C20H20ClN5O3S2
Molecular Weight:
477.98
Pathway:
Membrane transporter/Ion channel|Neuroscience
Purity:
0.98
SMILES:
CN1CCN(CC1)C(=O)OC1N(C(=O)C2=C1SCCS2)c1ccc2ccc(Cl)nc2n1
Target:
GABA Receptor

References

1. Morishita H, Kushiku K, Matsuki J, Tokunaga T, Inoue T, Mori R, Kawamoto H, Furukawa T. Pharmacological effects of the antianxiety compound suriclone and its principal metabolites. Arzneimittelforschung. 1987 Dec;37(12):1332-40. PubMed PMID: 2896505. 2. Ono H, Morishita S, Kasuya M, Kobayashi M, Miyamoto M, Oka J, Goto M, Fukuda H. Comparison of the effects of the new anxiolytic suriclone and benzodiazepines on motor function and electroencephalogram. Arzneimittelforschung. 1987 Apr;37(4):384-8. PubMed PMID: 2886128. 3. Semlitsch HV, Anderer P, Saletu B. Acute effects of the anxiolytics suriclone and alprazolam on cognitive information processing utilizing topographic mapping of event-related brain potentials (P300) in healthy subjects. Eur J Clin Pharmacol. 1995;49(3):183-91. PubMed PMID: 8665994. 4. Perault MC, Chapelle G, Bouquet S, Chevalier P, Montay G, Gaillot J, Chakroun H, Guillet P, Vandel B. Pharmacokinetic and pharmacodynamic study of suriclone imipramine interaction in man. Fundam Clin Pharmacol. 1994;8(3):251-5. PubMed PMID: 7927120.